SCHEMBL10155732

SCHEMBL10155732

N#CNCc1cccc([N+](=O)[O-])c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
MAPT P10636 3/20 0.54
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
POLB P06746 1/20 0.54
CYP19A1 P11511 1/20 0.51
ALDH1A1 P00352 3/20 0.51
CYP2C19 P33261 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
LMNA P02545 1/20 0.50
KDM1A O60341 2/20 0.49
MAOA P21397 2/20 0.49
MAOB P27338 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
PTPN1 P18031 1/20 0.49
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2565526 0.81 KMT2A (0.61) TSHRMAPTKMT2AMEN1POLB
Hydrochloric Acid SCHEMBL5622098 0.80 KMT2A (0.60) TSHRMAPTKMT2AMEN1POLB
SCHEMBL347820 0.78 TSHR (0.61) TSHRMAPTKMT2AMEN1POLB
SCHEMBL172796 0.78 TSHR (0.61) TSHRMAPTKMT2AMEN1POLB
SCHEMBL28219452 0.78 TSHR (0.61) TSHRMAPTKMT2AMEN1POLB
SCHEMBL1829879 0.78 TSHR (0.61) TSHRMAPTKMT2AMEN1POLB
SCHEMBL28219453 0.78 TSHR (0.61) TSHRMAPTKMT2AMEN1POLB
SCHEMBL13219674 0.78 TSHR (0.66) TSHRMAPTKMT2AMEN1POLB
Hydrochloric Acid SCHEMBL21801320 0.77 TSHR (0.59) TSHRMAPTKMT2AMEN1POLB
SCHEMBL30482083 0.77 TSHR (0.59) TSHRMAPTKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120015961-A1 ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015961-A1 ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY BACE1, BACE2, APP TSHR 837/4885MAPT 40/4885KMT2A 1656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.